Bain Capital Life Sciences Opportunities III reported a 4.75% stake in Kyverna Therapeutics KYTX · 2,885,000 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 4.75%
Last report: 5.4% · filed 26/02/17
Shares held: 2,885,000 sh
Class: Common Stock, $0.00001 par value per share
Stock: Kyverna Therapeutics KYTX
Holder: Bain Capital Life Sciences Opportunities III
Event date: 26/06/30
Filed: 26/08/14

4.75% stake · below 5%

Stake: 4.75%
Last report: 5.4%
Since last report: −0.7pp

Kyverna Therapeutics trades, last 26 weeks

What else happened in Kyverna Therapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Bain Capital Life Sciences Opportunities III's other 5% stake reports

No other trades yet.